ATHEROSCLEROSIS

ATHEROSCLEROSIS:

• 2019
• Medical Marijuana For Atherosclerosis (news–2019)
  https://www.marijuanadoctors.com/conditions/atherosclerosis/
• Deficiency of Monoacylglycerol Lipase Enhances IgM Plasma Levels and Limits Atherogenesis in a CB2-Dependent Manner. (Germay/ Finland/ Switzerland/ USA/ Netherlands, full, 2019) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0038-1676769 
• Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle. (Saudi Arabia, full, 2019) http://www.jmau.org/article.asp?issn=2213-879X;year=2018;volume=6;issue=4;spage=171;epage=176;aulast=Eid 
• New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota. (Iran, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203867/ 
• Endocannabinoid Signalling in Atherosclerosis and Related Metabolic Complications. (Germany, 1st page, 2019) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1678738 
• Role of the endocannabinoidome in human and mouse atherosclerosis. (Canada/ Italy, abstract, 2019) https://pubmed.ncbi.nlm.nih.gov/31448709/ 
• Ameliorative effects of hempseed (Cannabis sativa) against hypercholesterolemia associated cardiovascular changes. (India, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S093947531930345X 
• 2018
• Can Cannabis Effectively Treat Atherosclerosis? (news–2018)
  https://www.royalqueenseeds.com/blog-can-cannabis-effectively-treat-atherosclerosis-n742
• Tobacco more strongly linked to clogged arteries than cannabis (news–2018)
  https://www.swissinfo.ch/eng/smoking-and-heart-disease_tobacco-more-strongly-linked-to-clogged-arteries-than-cannabis/44043526
• Endocannabinoids in Caenorhabditis elegans are essential for the mobilization of cholesterol from internal reserves. (Argentina/ Germany/ USA, full, 2018) https://www.nature.com/articles/s41598-018-24925-8 
• Cannabinoids, the Heart of the Matter. (USA, full, 2018) https://www.ahajournals.org/doi/full/10.1161/JAHA.118.009099 
• The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2. (USA, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020134/ 
• Ca2+-dependent potassium channels and cannabinoid signaling in the endothelium of apolipoprotein E knockout mice before plaque formation. (Ukraine/ Italy/ Switzerland, abstract, 2018) https://www.sciencedirect.com/science/article/abs/pii/S0022282818300026 
• Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB1 cannabinoid receptor-deficient mice. (Japan/ USA, abstract, 2018) https://pubmed.ncbi.nlm.nih.gov/30265576/ 
• 2017
• The role of exercise training and the endocannabinoid system in atherosclerotic plaque burden and composition in Apo-E-deficient mice. (Greece, full, 2017) https://www.sciencedirect.com/science/article/pii/S1109966616302949 
• Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention. (USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665427/ 
• Exercise versus targeting of endocannabinoid system for atheromatic plaque stabilization. Opposing or complementary roles? (Greece, link to PDF, 2017) https://www.researchgate.net/publication/316356545_Exercise_versus_targeting_of_endocannabinoid_system_for_atheromatic_plaque_stabilization_Opposing_or_complementary_roles 
• Cannabinoids in the Cardiovascular System. (UK/ Canada, partial preview, 2017) https://books.google.com/books?id=djRHDgAAQBAJ&pg=PA329&lpg=PA329&dq=%22Chapter+Ten+-+Cannabinoids+in+the+Cardiovascular+System%22&source=bl&ots=QXJdVSt-WA&sig=ACfU3U0viRFFCYzWd9NIVLl99cfuXeQmiQ&hl=en&sa=X&ved=2ahUKEwjWner86dbmAhVXjp4KHYtDBCEQ6AEwAnoECAcQAQ#v=onepage&q=%22Chapter%20Ten%20-%20Cannabinoids%20in%20the%20Cardiovascular%20System%22&f=false 
• Prospects for the Use of Cannabinoid Receptor Ligands for the Treatment of Metabolic Syndrome and Atherosclerosis: Analysis of Experimental and Clinical Data. (Russia, abstract, link to full PDF in Russian, 2017) https://www.semanticscholar.org/paper/%5BProspects-for-the-Use-of-Cannabinoid-Receptor-for-Maslov-Karpov/d01b44c406ef1941709b0c18e10b314adbec6778 
• Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalulation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis. (Switzerland, abstract, 2017) https://www.sciencedirect.com/science/article/abs/pii/S096980511630261X?via%3Dihub 
• Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment. (China, abstract, 2017) https://www.semanticscholar.org/paper/Inhibitory-effect-of-trans%E2%80%90caryophyllene-(TC)-on-Zhang-Yang/617d75bb627424dcac225b2dbb96d66bdb6e0745 
• The endocannabinoid system in cardiovascular function: novel insights and clinical implications. (USA/ Australia/ Spain, abstract, 2017) https://link.springer.com/article/10.1007%2Fs10286-017-0488-5   
• 2016
• Studies Suggest Cannabis Can Counter the Progression of Atherosclerosis (news–2016) https://www.marijuanatimes.org/studies-suggest-cannabis-can-counter-the-progression-of-atherosclerosis/
• The CB2 receptor and its role as a regulator of inflammation. (Canada, full, 2016) https://link.springer.com/article/10.1007/s00018-016-2300-4 
• Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice. (Austria, full, 2016) https://www.sciencedirect.com/science/article/pii/S0021915015301933 
• Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS/MS. (USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889016/ 
• Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice. (Germany/ USA, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712127/ 
• Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase. (USA/ China, full, 2016) https://journals.physiology.org/doi/full/10.1152/ajpcell.00251.2015 
• Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review). (Slovenia, full, 2016) https://www.spandidos-publications.com/10.3892/ijmm.2016.2779 
• Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis. (Italy, abstract, 2016) https://www.semanticscholar.org/paper/Treatment-with-the-GPR55-antagonist-CID16020046-in-Montecucco-Bondarenko/b176484dc233bee8678db62b0419e860ff798a7f 
• N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNFα-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α. (China, abstract, 2016) https://pubmed.ncbi.nlm.nih.gov/27281236/ 
• Selective activation of CB2 receptor improves efferocytosis in cultured macrophages. (China, abstract, 2016) https://www.sciencedirect.com/science/article/abs/pii/S0024320516304325?via%3Dihub 
• 2015
• Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. (Japan, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315049/ 
• Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages. (Italy, full, 2015) https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839 
• Oxyradical Stress, Endocannabinoids, and Atherosclerosis. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686160/ 
• Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212- 2 on Atherosclerosis in Ldlr-null Mice. (USA, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581537/ 
• Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque. (Romania, link to PDF, 2015) https://www.researchgate.net/publication/284713494_Beyond_Lipoprotein_Receptors_Learning_from_Receptor_Knockouts_Mouse_Models_about_New_Targets_for_Reduction_of_the_Atherosclerotic_Plaque 
• Endocannabinoids and the Cardiovascular System in Health and Disease. (UK, partial preview, 2015) https://books.google.com/books?hl=en&lr=&id=QwihCgAAQBAJ&oi=fnd&pg=PA392&ots=FMMqDAFSlE&sig=LWKPj_N-avs3SF1248d1Yu7g5CI#v=onepage&q&f=false 
• Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer's Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline. (Italy, abstract, 2015) https://pubmed.ncbi.nlm.nih.gov/25818503/ 
• The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (Greece, abstract, 2015) https://www.semanticscholar.org/paper/The-effect-of-endocannabinoid-system-in-injury%3A-a-a-Moris-Georgopoulos/066507b72d1891d78734f703781231ac05910d09 
• Abstract 577: Medical Marijuana Use: Effect on Lipid Metabolism and Atherosclerosis. (USA, abstract, 2015) https://www.ahajournals.org/doi/abs/10.1161/atvb.35.suppl_1.577 
• 2014
• New Study: Cannabis May Treat Atherosclerosis (news–2014)  https://thejointblog.com/new-study-cannabis-may-treat-atherosclerosis/
• 2011
• Cannabinoinds Therapeutic Effects on ATHEROSCLEROSIS, Medical Cannabis Marijuana Research Cannabidiol THC (news–2011)
  https://montanabiotech.com/2011/09/06/cannabinoinds-therapeutic-effects-on-atherosclerosis-medical-cannabis-marijuana-research-cannabidiol-thc/